Drug rebate agreements under open-house procedure
Original notice title
Germany – Pharmaceutical products – Arzneimittelrabattverträge gem. § 130a Abs. 8 SGB V im Rahmen von Open-House-Verfahren
Opportunity Score
Why this score?
Opportunity
52 / 100
Complexity
68 / 100
Risk factors
Electronic submission is explicitly not allowed; the XML notice says the authority cannot access electronically submitt...
The procedure is restricted to pharmaceutical undertakings or consortia of pharmaceutical undertakings under § 4(18) AM...
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Overview
Moderate opportunityKey Facts
- Supplies contract
- 3 lots
- Duration until Dec 2027
- Open-house pharmaceutical rebate agreements under § 130a(8) SGB V for 53 listed active substances or combinations.
- Supply of pharmaceutical products in Germany, with place of performance in DEU / DED21.
Show full summary
Open-house procedure by IKK classic for non-exclusive pharmaceutical rebate agreements under § 130a(8) SGB V, covering 53 listed active substances/combination products in Germany. The notice is open to interested and suitable pharmaceutical companies only, with equal non-negotiable conditions and no electronic submission allowed; documents must be sent by post or email. No contract value is stated in the structured data or XML notice.
Risks
Electronic submission is explicitly not allowed; the XML notice says the authority cannot access electronically submitt...
The procedure is restricted to pharmaceutical undertakings or consortia of pharmaceutical undertakings under § 4(18) AM...
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
Eligibility
- Only pharmaceutical companies or consortia of pharmaceutical companies within the meaning of § 4(18) AMG are eligible.
Administrative
- Signed contract plus all required proofs, self-declarations, and documents must be submitted.
- According to the XML notice, additional required document: commercial register extract not older than six months at contract start.
Buyer
Lots (53)
LOT-0001
Amoxicillin
Supply lot for Amoxicillin (ATC J01CA04). Open-house rebate agreement under equal, non-negotiable conditions. Performance in Germany (DED21).
Location
Duration
Category
Deadline
Award details
Amoxicillin
ATC-Code: J01CA04
Value note
Show original TED data
Original lot title
Amoxicillin; ATC-Code: J01CA04
Original TED description
Amoxicillin; ATC-Code: J01CA04
LOT-0002
Amoxicillin and clavulanic acid
Supply lot for Amoxicillin and clavulanic acid (ATC J01CR02). Open-house rebate agreement under equal, non-negotiable conditions. Performance in Germany (DED21).
Location
Duration
Category
Deadline
Award details
Amoxicillin und Clavulansäure
ATC-Code: J01CR02
Value note
Show original TED data
Original lot title
Amoxicillin und Clavulansäure; ATC-Code: J01CR02
Original TED description
Amoxicillin und Clavulansäure; ATC-Code: J01CR02
LOT-0003
Apremilast
Supply lot for Apremilast (ATC L04AA32). Open-house rebate agreement under equal, non-negotiable conditions. Performance in Germany (DED21).
Location
Duration
Category
Deadline
Award details
Apremilast
ATC-Code: L04AA32
Value note
Show original TED data
Original lot title
Apremilast; ATC-Code: L04AA32
Original TED description
Apremilast; ATC-Code: L04AA32
LOT-0004
Azithromycin; ATC-Code: J01FA10
Azithromycin; ATC-Code: J01FA10
Location
Duration
Category
Award details
Azithromycin
ATC-Code: J01FA10
LOT-0005
Belimumab; ATC-Code:L04AG04
Belimumab; ATC-Code:L04AG04
Location
Duration
Category
Award details
Belimumab
ATC-Code:L04AG04
LOT-0006
Betamethason und Fusidinsäure; ATC-Code: D07CC01
Betamethason und Fusidinsäure; ATC-Code: D07CC01
Location
Duration
Category
Award details
Betamethason und Fusidinsäure
ATC-Code: D07CC01
LOT-0007
Buprenorphin; Pflaster transdermal; Tragedauer 3 Tage; ATC-Code: N02AE01
Buprenorphin; Pflaster transdermal; Tragedauer 3 Tage; ATC-Code: N02AE01
Location
Duration
Category
Award details
Buprenorphin
Pflaster transdermal
Tragedauer 3 Tage
ATC-Code: N02AE01
LOT-0008
Calciumcarbonat und Colecalciferol; ATC-Code: A12AX01 (ADV); A12AX (WHO)
Calciumcarbonat und Colecalciferol; ATC-Code: A12AX01 (ADV); A12AX (WHO)
Location
Duration
Category
Award details
Calciumcarbonat und Colecalciferol
ATC-Code: A12AX01 (ADV)
A12AX (WHO)
LOT-0009
Carbamazepin; Retardtabletten; ATC-Code: N03AF01
Carbamazepin; Retardtabletten; ATC-Code: N03AF01
Location
Duration
Category
Award details
Carbamazepin
Retardtabletten
ATC-Code: N03AF01
LOT-0010
Ceftriaxon; ATC-Code: J01DD04
Ceftriaxon; ATC-Code: J01DD04
Location
Duration
Category
Award details
Ceftriaxon
ATC-Code: J01DD04
LOT-0011
Cefuroxim; ATC-Code: J01DC02
Cefuroxim; ATC-Code: J01DC02
Location
Duration
Category
Award details
Cefuroxim
ATC-Code: J01DC02
LOT-0012
Ciprofloxacin; ATC-Code: J01MA02
Ciprofloxacin; ATC-Code: J01MA02
Location
Duration
Category
Award details
Ciprofloxacin
ATC-Code: J01MA02
LOT-0013
Clindamycin; ATC-Code: J01FF01
Clindamycin; ATC-Code: J01FF01
Location
Duration
Category
Award details
Clindamycin
ATC-Code: J01FF01
LOT-0014
Doravirin; ATC-Code: J05AG06
Doravirin; ATC-Code: J05AG06
Location
Duration
Category
Award details
Doravirin
ATC-Code: J05AG06
LOT-0015
Doxycyclin; ATC-Code: J01AA02
Doxycyclin; ATC-Code: J01AA02
Location
Duration
Category
Award details
Doxycyclin
ATC-Code: J01AA02
LOT-0016
Elbasvir und Grazoprevir; ATC-Code: J05AP54
Elbasvir und Grazoprevir; ATC-Code: J05AP54
Location
Duration
Category
Award details
Elbasvir und Grazoprevir
ATC-Code: J05AP54
LOT-0017
Escitalopram; Tropfen zum Einnehmen; ATC-Code: N06AB10
Escitalopram; Tropfen zum Einnehmen; ATC-Code: N06AB10
Location
Duration
Category
Award details
Escitalopram
Tropfen zum Einnehmen
ATC-Code: N06AB10
LOT-0018
Estradiol; Filmtabletten; ATC-Code: G03CA03
Estradiol; Filmtabletten; ATC-Code: G03CA03
Location
Duration
Category
Award details
Estradiol
Filmtabletten
ATC-Code: G03CA03
LOT-0019
Fentanyl; Pflaster transdermal; Wirkstoffmenge 4,8 mg, 9,6 mg, 14,4 mg und 19,2 mg; ATC-Code: N02AB03
Fentanyl; Pflaster transdermal; Wirkstoffmenge 4,8 mg, 9,6 mg, 14,4 mg und 19,2 mg; ATC-Code: N02AB03
Location
Duration
Category
Award details
Fentanyl
Pflaster transdermal
Wirkstoffmenge 4,8 mg, 9,6 mg, 14,4 mg und 19,2 mg
ATC-Code: N02AB03
LOT-0020
Fesoterodin; ATC-Code: G04BD11
Fesoterodin; ATC-Code: G04BD11
Location
Duration
Category
Award details
Fesoterodin
ATC-Code: G04BD11
LOT-0021
Fosfomycin; ATC-Code: J01XX01
Fosfomycin; ATC-Code: J01XX01
Location
Duration
Category
Award details
Fosfomycin
ATC-Code: J01XX01
LOT-0022
Galsulfase; ATC-Code: A16AB08
Galsulfase; ATC-Code: A16AB08
Location
Duration
Category
Award details
Galsulfase
ATC-Code: A16AB08
LOT-0023
Glyceroltrinitrat; Salbe; ATC-Code: C05AE01
Glyceroltrinitrat; Salbe; ATC-Code: C05AE01
Location
Duration
Category
Award details
Glyceroltrinitrat
Salbe
ATC-Code: C05AE01
LOT-0024
Guanfacin; ATC-Code: N06BA21 (ADV); C02AC02 (WHO)
Guanfacin; ATC-Code: N06BA21 (ADV); C02AC02 (WHO)
Location
Duration
Category
Award details
Guanfacin
ATC-Code: N06BA21 (ADV)
C02AC02 (WHO)
LOT-0025
Haloperidol; Injektionslösung; ATC-Code: N05AD01
Haloperidol; Injektionslösung; ATC-Code: N05AD01
Location
Duration
Category
Award details
Haloperidol
Injektionslösung
ATC-Code: N05AD01
LOT-0026
Hydrochlorothiazid und Triamteren; ATC-Code: C03EA21 (ADV); C03EA01 (WHO)
Hydrochlorothiazid und Triamteren; ATC-Code: C03EA21 (ADV); C03EA01 (WHO)
Location
Duration
Category
Award details
Hydrochlorothiazid und Triamteren
ATC-Code: C03EA21 (ADV)
C03EA01 (WHO)
LOT-0027
Ipratropiumbromid; Dosieraerosol; ATC-Code: R03BB01
Ipratropiumbromid; Dosieraerosol; ATC-Code: R03BB01
Location
Duration
Category
Award details
Ipratropiumbromid
Dosieraerosol
ATC-Code: R03BB01
LOT-0028
Lactulose; Sirup; ATC-Code: A06AD11
Lactulose; Sirup; ATC-Code: A06AD11
Location
Duration
Category
Award details
Lactulose
Sirup
ATC-Code: A06AD11
LOT-0029
Lamivudin, Tenofovirdisoproxil und Doravirin; ATC-Code: J05AR24
Lamivudin, Tenofovirdisoproxil und Doravirin; ATC-Code: J05AR24
Location
Duration
Category
Award details
Lamivudin, Tenofovirdisoproxil und Doravirin
ATC-Code: J05AR24
LOT-0030
Levodopa und Carbidopa; Retardtabletten; ATC-Code: N04BA10 (ADV); N04BA02 (WHO)
Levodopa und Carbidopa; Retardtabletten; ATC-Code: N04BA10 (ADV); N04BA02 (WHO)
Location
Duration
Category
Award details
Levodopa und Carbidopa
Retardtabletten
ATC-Code: N04BA10 (ADV)
N04BA02 (WHO)
LOT-0031
Levothyroxin-Natrium; ATC-Code: H03AA01
Levothyroxin-Natrium; ATC-Code: H03AA01
Location
Duration
Category
Award details
Levothyroxin-Natrium
ATC-Code: H03AA01
LOT-0032
Macrogol, Kombinationen; Pulver zur Herstellung einer Lösung zum Einnehmen; ATC-Code: A06AD65
Macrogol, Kombinationen; Pulver zur Herstellung einer Lösung zum Einnehmen; ATC-Code: A06AD65
Location
Duration
Category
Award details
Macrogol, Kombinationen
Pulver zur Herstellung einer Lösung zum Einnehmen
ATC-Code: A06AD65
LOT-0033
Methyldopa (linksdrehend); ATC-Code: C02AB01
Methyldopa (linksdrehend); ATC-Code: C02AB01
Location
Duration
Category
Award details
Methyldopa (linksdrehend)
ATC-Code: C02AB01
LOT-0034
Methylprednisolon; Pulver u. Lösungsm. z. Herst. e. Injektions- bzw. Infusionsl.; ATC-Code: H02AB04
Methylprednisolon; Pulver u. Lösungsm. z. Herst. e. Injektions- bzw. Infusionsl.; ATC-Code: H02AB04
Location
Duration
Category
Award details
Methylprednisolon
Pulver u. Lösungsm. z. Herst. e. Injektions- bzw. Infusionsl.
ATC-Code: H02AB04
LOT-0035
Metronidazol; ATC-Code: P01AB01
Metronidazol; ATC-Code: P01AB01
Location
Duration
Category
Award details
Metronidazol
ATC-Code: P01AB01
LOT-0036
Moxifloxacin; ATC-Code: J01MA14
Moxifloxacin; ATC-Code: J01MA14
Location
Duration
Category
Award details
Moxifloxacin
ATC-Code: J01MA14
LOT-0037
Nifedipin; ATC-Code: C08CA05
Nifedipin; ATC-Code: C08CA05
Location
Duration
Category
Award details
Nifedipin
ATC-Code: C08CA05
LOT-0038
Norethisteron und Estradiol; ATC-Code: G03FA01
Norethisteron und Estradiol; ATC-Code: G03FA01
Location
Duration
Category
Award details
Norethisteron und Estradiol
ATC-Code: G03FA01
LOT-0039
Octreotid; ATC-Code: H01CB02
Octreotid; ATC-Code: H01CB02
Location
Duration
Category
Award details
Octreotid
ATC-Code: H01CB02
LOT-0040
Pamidronsäure; ATC-Code: M05BA03
Pamidronsäure; ATC-Code: M05BA03
Location
Duration
Category
Award details
Pamidronsäure
ATC-Code: M05BA03
LOT-0041
Pazopanib; ATC-Code: L01EX03
Pazopanib; ATC-Code: L01EX03
Location
Duration
Category
Award details
Pazopanib
ATC-Code: L01EX03
LOT-0042
Piracetam; Filmtabletten; ATC-Code: N06BX03
Piracetam; Filmtabletten; ATC-Code: N06BX03
Location
Duration
Category
Award details
Piracetam
Filmtabletten
ATC-Code: N06BX03
LOT-0043
Prednison; ATC-Code: H02AB07
Prednison; ATC-Code: H02AB07
Location
Duration
Category
Award details
Prednison
ATC-Code: H02AB07
LOT-0044
Rabeprazol; ATC-Code: A02BC04
Rabeprazol; ATC-Code: A02BC04
Location
Duration
Category
Award details
Rabeprazol
ATC-Code: A02BC04
LOT-0045
Rivaroxaban; ohne Wirkstärke 2,5 mg; ATC-Code: B01AF01
Rivaroxaban; ohne Wirkstärke 2,5 mg; ATC-Code: B01AF01
Location
Duration
Category
Award details
Rivaroxaban
ohne Wirkstärke 2,5 mg
ATC-Code: B01AF01
LOT-0046
Salbutamol und Ipratropiumbromid; ATC-Code: R03AL02
Salbutamol und Ipratropiumbromid; ATC-Code: R03AL02
Location
Duration
Category
Award details
Salbutamol und Ipratropiumbromid
ATC-Code: R03AL02
LOT-0047
Salmeterol; ATC-Code: R03AC12
Salmeterol; ATC-Code: R03AC12
Location
Duration
Category
Award details
Salmeterol
ATC-Code: R03AC12
LOT-0048
Tacrolimus; Hartkapseln; ATC-Code: L04AD02
Tacrolimus; Hartkapseln; ATC-Code: L04AD02
Location
Duration
Category
Award details
Tacrolimus
Hartkapseln
ATC-Code: L04AD02
LOT-0049
Tobramycin; Lösung für einen Vernebler; ATC-Code: J01GB01
Tobramycin; Lösung für einen Vernebler; ATC-Code: J01GB01
Location
Duration
Category
Award details
Tobramycin
Lösung für einen Vernebler
ATC-Code: J01GB01
LOT-0050
Tolvaptan; Tabletten; Wirkstärke 7,5 mg und 30 mg; Packungsgröße 30 TAB; ATC-Code: C03XA01
Tolvaptan; Tabletten; Wirkstärke 7,5 mg und 30 mg; Packungsgröße 30 TAB; ATC-Code: C03XA01
Location
Duration
Category
Award details
Tolvaptan
Tabletten
Wirkstärke 7,5 mg und 30 mg
Packungsgröße 30 TAB
ATC-Code: C03XA01
LOT-0051
Triamcinolon; ATC-Code: D07AB09
Triamcinolon; ATC-Code: D07AB09
Location
Duration
Category
Award details
Triamcinolon
ATC-Code: D07AB09
LOT-0052
Valproinsäure; Filmtabletten magensaftresistent; ATC-Code: N03AG01
Valproinsäure; Filmtabletten magensaftresistent; ATC-Code: N03AG01
Location
Duration
Category
Award details
Valproinsäure
Filmtabletten magensaftresistent
ATC-Code: N03AG01
LOT-0053
Valproinsäure; Retardtabletten; ATC-Code: N03AG01
Valproinsäure; Retardtabletten; ATC-Code: N03AG01
Location
Duration
Category
Award details
Valproinsäure
Retardtabletten
ATC-Code: N03AG01
Procurement Details
- Publication date
- 16 Nov 2025
- Languages
- German
Reference metadata
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 759734-2025
Documents (1)
Similar tenders
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)
Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР
Belgium – Pharmaceutical products – Antimycotica
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)
Denmark – Pharmaceutical products – Amgros 2027 1.1170.a
Opportunity Score
Why this score?
Opportunity
52 / 100
Complexity
68 / 100
Risk factors
Electronic submission is explicitly not allowed; the XML notice says the authority cannot access electronically submitt...
The procedure is restricted to pharmaceutical undertakings or consortia of pharmaceutical undertakings under § 4(18) AM...
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications